MTLS logo

Materialise NV Stock Price

NasdaqGS:MTLS Community·US$376.3m Market Cap
  • 1 Narratives written by author
  • 1 Comments on narratives written by author
  • 29 Fair Values set on narratives written by author

MTLS Share Price Performance

US$6.20
1.16 (23.02%)
31.1% undervalued intrinsic discount
US$8.99
Fair Value
US$6.20
1.16 (23.02%)
31.0% undervalued intrinsic discount
US$8.99
Fair Value
Price US$6.20
AnalystConsensusTarget US$8.99

MTLS Community Narratives

AnalystConsensusTarget·
Fair Value US$8.99 31.1% undervalued intrinsic discount

Personalized Healthcare And Automation Will Unlock Future Markets

0users have liked this narrative
1users have commented on this narrative
21users have followed this narrative

Recent MTLS News & Updates

Materialise NV's (NASDAQ:MTLS) P/E Is On The Mark

Oct 06
Materialise NV's (NASDAQ:MTLS) P/E Is On The Mark

Materialise: Automotive Weakness Is Undermining The Stock

Jul 28

Analyst Estimates: Here's What Brokers Think Of Materialise NV (NASDAQ:MTLS) After Its Second-Quarter Report

Jul 27
Analyst Estimates: Here's What Brokers Think Of Materialise NV (NASDAQ:MTLS) After Its Second-Quarter Report

Materialise (NASDAQ:MTLS) Is Looking To Continue Growing Its Returns On Capital

Jul 25
Materialise (NASDAQ:MTLS) Is Looking To Continue Growing Its Returns On Capital

After Leaping 28% Materialise NV (NASDAQ:MTLS) Shares Are Not Flying Under The Radar

May 04
After Leaping 28% Materialise NV (NASDAQ:MTLS) Shares Are Not Flying Under The Radar

Materialise NV Key Details

€265.5m

Revenue

€115.4m

Cost of Revenue

€150.2m

Gross Profit

€144.5m

Other Expenses

€5.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
0.095
Gross Margin
56.55%
Net Profit Margin
2.12%
Debt/Equity Ratio
18.7%

Materialise NV Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Excellent balance sheet with moderate growth potential.

1 Risk
2 Rewards

About MTLS

Founded
1990
Employees
488
CEO
Brigitte de Vet-Veithen
WebsiteView website
www.materialise.com

Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, website, and picture archiving and communication system. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Belgian Market Performance

  • 7 Days: 2.1%
  • 3 Months: 6.9%
  • 1 Year: 8.5%
  • Year to Date: 13.2%
The market has climbed 2.1% in the last 7 days, lead by the Healthcare sector with a gain of 9.5%. In the last year, the market has climbed 8.5%. Looking forward, earnings are forecast to grow by 15% annually. Market details ›